Trial intelligence / Profile preview

Pediatric study of multiple formulations of pandemic swine-origin A/H1N1 influenza vaccine

2009-013346-83Phase 2Completed

Sponsor
Sanofi
Start
Jul 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2 trial of pandemic A/H1N1 influenza vaccine in influenza A virus infection (H1N1) (4 arms), sponsored by Sanofi. Primary endpoints: Immunogenicity by HAI and SN testing after each vaccination and Safety. Started Jul 2009; status: completed.

02

Drugs

pandemic A/H1N1 influenza vaccine
03

Conditions

influenza A virus infection (H1N1)

Beyond the preview

Go deeper on 2009-013346-83.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013346-83.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call